
Dec 15 (Reuters) - Cencora Inc COR.N:
CENCORA OUTLOOK FY ADJUSTED EPS USD 17.45-17.75
CENCORA - TO BUY MAJORITY STAKE IN ONEONCOLOGY
CENCORA - ONEONCOLOGY VALUED AT $7.4 BILLION IN DEAL
CENCORA - TO BUY STAKE IN ONEONCOLOGY FOR $3.6 BILLION
CENCORA - TO FUND DEAL WITH NEW DEBT FINANCING
CENCORA - RAISES LONG-TERM GUIDANCE FOR ADJUSTED OPERATING INCOME AND ADJUSTED EPS
CENCORA - EXPECTS DEAL TO BE ABOUT NEUTRAL, NET OF FINANCING COSTS, TO CO'S ADJUSTED DILUTED EPS IN FIRST TWELVE MONTHS FOLLOWING CLOSE
CENCORA OUTLOOK LONG-TERM ADJUSTED OPERATING INCOME 7% TO 10%
CENCORA - IN ANTICIPATION OF COMPANY'S ACQUISITION OF ONEONCOLOGY, IT IS PAUSING SHARE REPURCHASES
CENCORA - MORE LIKELY COMPANY'S FULL YEAR ADJUSTED DILUTED EPS WILL BE TOWARDS LOWER HALF OF ITS GUIDANCE RANGE OF $17.45 TO $17.75
CENCORA - SEES LONG-TERM ADJUSTED DILUTED EARNINGS PER SHARE UP 10% TO 14%
CENCORA - REITERATES FISCAL 2026 GUIDANCE